POLIVY (polatuzumab vedotin-piiq) for injection

POLIVY is a CD79b-directed antibody–drug conjugate indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies. Brand Name: POLIVY (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 2019

Home | (polatuzumab vedotin-piiq) for injection

POLIVY (polatuzumab vedotin-piiq) for injection Price In India and Overseas
POLIVY (polatuzumab vedotin-piiq) for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

POLIVY (polatuzumab vedotin-piiq) for injection

Polatuzumab vedotin-piiq is approved to treat: Diffuse large B-cell lymphoma (DLBCL). Polatuzumab vedotin-piiq is also being studied in the treatment of other types of cancer.

A drug used with other drugs to treat adults with certain types of diffuse large B-cell lymphoma. It is also being studied in the treatment of other types of cancer. Polivy contains a monoclonal antibody that binds to a protein called CD79B, which is found on B cells (a type of white blood cell) and some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Polivy is a type of antibody-drug conjugate. Also called polatuzumab vedotin.
POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL).

Polatuzumab vedotin is indicated in combination with bendamustine and a rituximab product for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma. It is used:
With rituximab, cyclophosphamide, doxorubicin hydrochloride, and prednisone as the first treatment in adults who have low-intermediate to high-risk DLBCL or high-grade B-cell lymphoma. With bendamustine hydrochloride and rituximab in adults whose DLBCL has come back or has not gotten better after at least two other therapies.

Drug (Brand / Generic): POLIVY / polatuzumab vedotin-piiq
Current Indications: Diffuse large B-cell lymphoma (DLBCL)
Marketed by:: Genentech
Approval Date: 2019

Dosage forms and strengths of POLIVY (polatuzumab vedotin-piiq).
For injection: 140 mg of polatuzumab vedotin-piiq as a lyophilized powder in a single-dose vial.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “POLIVY (polatuzumab vedotin-piiq) for injection”.

Confirmation of the order for POLIVY (polatuzumab vedotin-piiq) for injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.

We have delivered medicines to following cities in India –  Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand POLIVY (polatuzumab vedotin-piiq) for injection. The import process requires a valid prescription and an Import License in the Patient’s Name.

For patients from following foreign countries seeking access to POLIVY (polatuzumab vedotin-piiq) for injection, they can inquire and find further information by sending their inquiries to ALS.

We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.

Kindly reach out to us for POLIVY (polatuzumab vedotin-piiq) for injection price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.